BlackRock Fund Advisors’s Abeona Therapeutics ABEO Stock Holding History

BlackRock Fund Advisors’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$203K	Buy	1,676 +79	+5%	+$12.4K	﹤0.01%	3422
2016 Q3	$240K	Buy	1,597 +131	+9%	+$12.8K	﹤0.01%	3391
2016 Q2	$87K	Sell	1,466 -10,624	-88%	-$726K	﹤0.01%	3708
2016 Q1	$774K	Buy	12,090 +949	+9%	+$62.8K	﹤0.01%	3204
2015 Q4	$936K	Buy	11,141 +286	+3%	+$28.7K	﹤0.01%	3240
2015 Q3	$1.1M	Sell	10,855 -124	-1%	-$16.5K	﹤0.01%	3200
2015 Q2	$1.39M	Buy	+10,979	New	+$1.65M	﹤0.01%	3194

Other funds holding ABEO

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock Fund Advisors's ABEO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Abeona Therapeutics (ABEO) stake by 4.9% in Q4 2016, buying an estimated $12.4K and bringing the position to 1,676 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #3422.

BlackRock Fund Advisors first reported a position in ABEO in Q2 2015 and has held it in 7 quarters since. The position peaked at $1.39M in Q2 2015. 54 funds tracked by Wall St. Rank hold ABEO as of Q4 2016.

BlackRock Fund Advisors held 1,676 shares of Abeona Therapeutics worth $203K as of Q4 2016.
BlackRock Fund Advisors bought 79 Abeona Therapeutics shares in Q4 2016, an estimated $12.4K.
Abeona Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3422 holding.
BlackRock Fund Advisors first reported a position in Abeona Therapeutics in Q2 2015 and has held it in 7 quarters since.
BlackRock Fund Advisors's Abeona Therapeutics position peaked at $1.39M in Q2 2015.
54 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.